Cell therapy strategies and improvements for muscular dystrophy

Quattrocelli, M.; Cassano, M.; Crippa, S.; Perini, I.; Sampaolesi, M.
August 2010
Cell Death & Differentiation;Aug2010, Vol. 17 Issue 8, p1222
Academic Journal
Understanding stem cell commitment and differentiation is a critical step towards clinical translation of cell therapies. In past few years, several cell types have been characterized and transplanted in animal models for different diseased tissues, eligible for a cell-mediated regeneration. Skeletal muscle damage is a challenge for cell- and gene-based therapeutical approaches, given the unique architecture of the tissue and the clinical relevance of acute damages or dystrophies. In this review, we will consider the regenerative potential of embryonic and somatic stem cells and the outcomes achieved on their transplantation into animal models for muscular dystrophy or acute muscle impairment.


Related Articles

  • Disciplining the Stem Cell into Myogenesis. Partridge, Terry // New England Journal of Medicine;4/27/2006, Vol. 354 Issue 17, p1844 

    The article discusses stem cell research in patients with muscular dystrophy. The author concentrates on one specific clinical trial that involved experimentation with bone marrow stem cells. The author discusses an in-vitro process of taking stem cells from the bone marrow and turning them into...

  • Application of MultiStem® allogeneic cells for immunomodulatory therapy: clinical progress and pre-clinical challenges in prophylaxis for graft versus host disease. Vaes, Bart; Van't Hof, Wouter; Deans, Robert; Pinxteren, Jef // Frontiers in Immunology;Nov2012, Vol. 3, p1 

    The last decade has seen much progress in adjunctive cell therapy for immune disorders. Both corporate and institutional Phase III studies have been run using mesenchymal stromal cells (MSC) for treatment of Graft versus Host Disease (GvHD), and product approval has been achieved for treatment...

  • In Mice, Stem Cell Transplant Can Repair Dystrophic Muscle. Breindl, Anette // BioWorld Today;7/11/2008, Vol. 19 Issue 134, p1 

    The article discusses a research on the possibility of stem cell transplant as treatment for Duchenne's muscular dystrophy. It references a study by Amy Wagers et al, published in the July 11, 2008 issue of the "Cell" journal. Information on Duchenne's muscular dystrophy is offered. Lead...

  • Myoblasts Derived From Normal hESCs and Dystrophic hiPSCs Efficiently Fuse With Existing Muscle Fibers Following Transplantation. Goudenege, Sébastien; Lebel, Carl; Huot, Nicolas B; Dufour, Christine; Fujii, Isao; Gekas, Jean; Rousseau, Joël; Tremblay, Jacques P // Molecular Therapy;Nov2012, Vol. 20 Issue 11, p2153 

    Human embryonic stem cells (hESCs) and human-induced pluripotent stem cells (hiPSCs) have an endless self-renewal capacity and can theoretically differentiate into all types of lineages. They thus represent an unlimited source of cells for therapies of regenerative diseases, such as Duchenne...

  • AMY WAGERS. Anthes, Emily // Discover;Dec2008, Vol. 29 Issue 12, p30 

    The article offers information about U.S. stem cell biologist Amy Wagers. The scientist researches adult stem cells that generate blood and muscle, by isolating cell populations and studying the way they are regulated by the human body. Research published by Wagers shows that muscle fiber...

  • Conditioning with α-emitter based radioimmunotherapy in canine allogeneic hematopoietic cell transplantation. Kornblit, Brian; Yun Chen; Sandmaier, Brenda M. // Chimerism;Apr-Jun2012, Vol. 3 Issue 2, p40 

    The article discusses a study which investigated the efficacy and safety α-emitter based radioimmunotherapy (RIT) as the only form of conditioning in a preclinical model of canine allogeneic hematopoietic cell transplantation (HCT). The study used the α-emitter bismuth-213 conjugated to...

  • Impact of Inflammatory Cytokine Gene Polymorphisms on Developing Acute Graft-versus-Host Disease in Children Undergoing Allogeneic Hematopoietic Stem Cell Transplantation. Masetti, Riccardo; Zama, Daniele; Urbini, Milena; Astolfi, Annalisa; Libri, Virginia; Vendemini, Francesca; Morello, William; Rondelli, Roberto; Prete, Arcangelo; Pession, Andrea // Journal of Immunology Research;4/20/2015, Vol. 2015, p1 

    Single nucleotide polymorphisms (SNPs) in gene encoding pro- and anti-inflammatory factors have been associated with the occurrence of aGvHD. We retrospectively tested a wide panel of 38 polymorphisms in 19 immunoregulatory genes, aiming to first establish, in a pediatric HSCT setting, which...

  • Undifferentiated spondyloarthritis following allogeneic stem cell transplantation. Karia, Vijay R.; Cuchacovich, Raquel; Espinoza, Luis R. // BMC Musculoskeletal Disorders;2010, Vol. 11, p132 

    Background: Stem cell transplant has been utilized in the treatment of malignancies and rheumatic disease. Rheumatic disease may be transferred from the donor with active disease or may be developed in a recipient de novo as a late complication of SCT. Case Presentation: We here report the rare...

  • European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. Hoenigl, Martin; Strenger, Volker; Buzina, Walter; Valentin, Thomas; Koidl, Christoph; Wölfler, Albert; Seeber, Katharina; Valentin, Angelika; Strohmeier, Anna T.; Zollner-Schwetz, Ines; Raggam, Reinhard B.; Urban, Christian; Lass-Flörl, Cornelia; Linkesch, Werner; Krause, Robert // Journal of Antimicrobial Chemotherapy (JAC);Aug2012, Vol. 67 Issue 8, p2029 

    Objectives Fulfilment of host factors defined by the revised European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) criteria is required for establishing the diagnosis of possible or probable invasive fungal infection (IFI). This case–control study...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics